Boehringer Ingelheim
Boehringer Ingelheim

Biotech Breakthrough! Quantro Therapeutics Cashes In
BIOT
📢 Austrian biotech company QUANTRO Therapeutics receives milestone payment from Boehringer Ingelheim for successful collaboration. 💰🔬💼

Huge €410M Licensing Deal for Fibro-Inflammatory Disease Treatments
BIOT
📣 Boehringer Ingelheim partners with Kyowa Kirin Co., Ltd. for €410m license deal to treat fibro-inflammatory diseases! 🧪💰





